• Home
  • Use cases
    • Whole exome sequencing
    • NGS panels
    • Carrier Screening
    • Liquid biopsy with NGS
    • Long-read sequencing
  • AION
  • Resources
    • Webinar series
    • Recommended publications
    • Blog
    • White paper
  • Academy
  • News
    • Press-releases
  • About us
    • Compliance
Follow us on LinkedIn and always stay up to date

 CONTACT

Limbus Medical Technologies achieves C5 attestation for the varvis® software

Rostock, Germany, November 4, 2025 — Limbus Medical Technologies GmbH, a medical device manufacturer and software development company based in Rostock, Germany, has achieved C5 attestation (type 1). This milestone reinforces the company's commitment to information security in cloud-based clinical genomics. For laboratories and hospitals, the result is a certified, secure cloud service that supports their compliance requirements.

“C5 attestation confirms what our customers expect from us: that sensitive clinical data is handled in a secure, certified cloud environment. We built the varvis® software with that responsibility in mind, and this attestation is independent proof that our controls work as designed. We are proud of the team that made it happen,” said Ben Liesfeld, Managing Director at Limbus.

The Cloud Computing Compliance Criteria Catalogue (C5), developed by Germany's Federal Office for Information Security (BSI), provides a framework for assessing the security of cloud services.

For clinical diagnostic laboratories, the secure handling of genomic data is an important consideration when selecting cloud-based software. As sequencing technologies and genomic analysis workflows continue to evolve, laboratories need solutions that support their diagnostic processes while addressing information security requirements.

The cloud-based varvis® software from Limbus Medical Technologies supports clinical diagnostic workflows across next-generation sequencing data processing, genomic data management, and variant interpretation.

This milestone complements Limbus’ existing certifications: its Quality Management System (QMS) is certified according to ISO 13485:2016, while the varvis® software (IVDR class C) holds a certificate under Regulation (EU) 2017/746 (IVDR). With quality and cloud security both independently assessed, the varvis® software offers laboratories and hospitals a single tool whose processes have been audited end to end, from software development to data hosting.

"Achieving C5 was a true team effort. Quality management and IT worked hand in hand from day one, and that close collaboration was the key to our success," said Inga Blunk, the regulatory expert responsible for the project at Limbus. Martin Garbe, Manager IT at Limbus, adds: "Achieving C5 meant reviewing every layer of our platform, from infrastructure and access management to incident response. The result is a cloud environment our customers can trust with sensitive clinical data."

 

About the varvis® software

The varvis® software is your complete solution for clinical diagnostics, combining NGS data processing, genomics data management, and variant interpretation in one seamless platform. Designed to streamline every step of the sequencing workflow, the varvis® software supports both short- and long-read technologies, enabling comprehensive genomic analysis from targeted panels to whole-genome sequencing. With automated analysis of SNVs, CNVs, STRs, and SVs, the varvis® software delivers robust performance, scalability, and accuracy across all panel sizes. It also serves as an integrated variant database for efficient knowledge management and full traceability. Now fully integrated with AION, the varvis® software brings AI-powered variant interpretation directly into your workflow. AION identifies and prioritizes disease-relevant variants, delivering a ranked shortlist and detailed report, and thus enabling faster, more confident diagnostics. As the first end-to-end genomics software certified as Class C under IVDR, the varvis® software sets the standard for clinical-grade performance and compliance.

Limbus Medical Technologies achieves C5 attestation for the varvis® software

Rostock, Germany, November 4, 2025 — Limbus Medical Technologies GmbH, a medical device manufacturer and software development company based in Rostock, Germany, has achieved C5 attestation (type 1). This milestone reinforces the company's commitment to information security in cloud-based clinical genomics. For laboratories and hospitals, the result is a certified, secure cloud service that supports their compliance requirements.

“C5 attestation confirms what our customers expect from us: that sensitive clinical data is handled in a secure, certified cloud environment. We built the varvis® software with that responsibility in mind, and this attestation is independent proof that our controls work as designed. We are proud of the team that made it happen,” said Ben Liesfeld, Managing Director at Limbus.

The Cloud Computing Compliance Criteria Catalogue (C5), developed by Germany's Federal Office for Information Security (BSI), provides a framework for assessing the security of cloud services.

For clinical diagnostic laboratories, the secure handling of genomic data is an important consideration when selecting cloud-based software. As sequencing technologies and genomic analysis workflows continue to evolve, laboratories need solutions that support their diagnostic processes while addressing information security requirements.

The cloud-based varvis® software from Limbus Medical Technologies supports clinical diagnostic workflows across next-generation sequencing data processing, genomic data management, and variant interpretation.

This milestone complements Limbus’ existing certifications: its Quality Management System (QMS) is certified according to ISO 13485:2016, while the varvis® software (IVDR class C) holds a certificate under Regulation (EU) 2017/746 (IVDR). With quality and cloud security both independently assessed, the varvis® software offers laboratories and hospitals a single tool whose processes have been audited end to end, from software development to data hosting.

"Achieving C5 was a true team effort. Quality management and IT worked hand in hand from day one, and that close collaboration was the key to our success," said Inga Blunk, the regulatory expert responsible for the project at Limbus. Martin Garbe, Manager IT at Limbus, adds: "Achieving C5 meant reviewing every layer of our platform, from infrastructure and access management to incident response. The result is a cloud environment our customers can trust with sensitive clinical data."

 

About the varvis® software

The varvis® software is your complete solution for clinical diagnostics, combining NGS data processing, genomics data management, and variant interpretation in one seamless platform. Designed to streamline every step of the sequencing workflow, the varvis® software supports both short- and long-read technologies, enabling comprehensive genomic analysis from targeted panels to whole-genome sequencing. With automated analysis of SNVs, CNVs, STRs, and SVs, the varvis® software delivers robust performance, scalability, and accuracy across all panel sizes. It also serves as an integrated variant database for efficient knowledge management and full traceability. Now fully integrated with AION, the varvis® software brings AI-powered variant interpretation directly into your workflow. AION identifies and prioritizes disease-relevant variants, delivering a ranked shortlist and detailed report, and thus enabling faster, more confident diagnostics. As the first end-to-end genomics software certified as Class C under IVDR, the varvis® software sets the standard for clinical-grade performance and compliance.

Get our latest news

Limbus Medical Technologies GmbH will use the information you provide on this form to send you our newsletter and all relevant information about us. You can change your mind at any time by clicking the unsubscribe link in the footer of any newsletter you receive from us, or by contacting us via dpo@limbus-medtec.com.

Contact

+49 381 2550 062-0

info@varvis.com
 

Contact us

Follow us

Follow us on LinkedIn and always stay up to date
Limbus Medical Technologies GmbH - Twitter

  • News
  • Contact us
  • Request a demo
  • Newsletter
  • Imprint
  • Privacy Policy
  • Investors
© 2015-2026 All Rights Reserved Limbus Medical Technologies GmbH

Cookie Notice

In addition to necessary cookies, which are essential for the functioning of our website, we use technically non-essential cookies and tracking mechanisms for optimal performance and for marketing purposes. These cookies are only used if you have given prior consent to such use. You can learn more about the use of cookies on our website in our privacy policy.

Click „Accept“ to accept the use of cookies to get the best experience on our website. You can also decline the use of cookies by closing this pop-up or by clicking "Decline".

 

Privacy policy | Imprint

Decline